In addition to the computational modeling and design, MMBC is also capable of doing the following:
- Preparation of computationally designed protein drug candidates
- Protein engineering to prolong the biological half-lives of protein drugs
- Development of stable cell lines for promising protein drug candidates
- Large-scale protein expression in a bioreactor and purification using an FPLC
- Advices for further preclinical and clinical development through CROs
The Molecular Modeling and Biopharmaceutical Center seeks new opportunities to develop innovative research partnerships with UK investigators. For more information and to request services, please contact us.